157 related articles for article (PubMed ID: 23696422)
21. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
22. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
23. PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders.
Shaw J; Scotchman E; Chandler N; Chitty LS
Reproduction; 2020 Nov; 160(5):A1-A11. PubMed ID: 32130205
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive prenatal diagnosis: progress and potential.
Daley R; Hill M; Chitty LS
Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F426-30. PubMed ID: 24786470
[TBL] [Abstract][Full Text] [Related]
25. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603
[TBL] [Abstract][Full Text] [Related]
26. Public viewpoints on new non-invasive prenatal genetic tests.
Farrimond HR; Kelly SE
Public Underst Sci; 2013 Aug; 22(6):730-44. PubMed ID: 23885055
[TBL] [Abstract][Full Text] [Related]
27. Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England.
Hill M; Taffinder S; Chitty LS; Morris S
Prenat Diagn; 2011 Mar; 31(3):267-73. PubMed ID: 21207386
[TBL] [Abstract][Full Text] [Related]
28. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
29. Prenatal whole exome sequencing: the views of clinicians, scientists, genetic counsellors and patient representatives.
Quinlan-Jones E; Kilby MD; Greenfield S; Parker M; McMullan D; Hurles ME; Hillman SC
Prenat Diagn; 2016 Oct; 36(10):935-941. PubMed ID: 27550507
[TBL] [Abstract][Full Text] [Related]
30. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
31. Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice.
Jenkins LA; Deans ZC; Lewis C; Allen S
Prenat Diagn; 2018 Jan; 38(1):44-51. PubMed ID: 29266293
[TBL] [Abstract][Full Text] [Related]
32. [Noninvasive prenatal genetic diagnosis: a bioethical reflection on the use of noninvasive prenatal diagnosis from the analysis of nucleic acids present in maternal peripheral blood].
González-Melado FJ; Di Pietro ML
Cuad Bioet; 2011; 22(74):49-75. PubMed ID: 21692554
[TBL] [Abstract][Full Text] [Related]
33. Expanded Carrier Screening.
Gregg AR
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
[TBL] [Abstract][Full Text] [Related]
34. A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.
Szczepura A; Osipenko L; Freeman K
BMC Pregnancy Childbirth; 2011 Jan; 11():5. PubMed ID: 21244652
[TBL] [Abstract][Full Text] [Related]
35. Carrier testing in children and adolescents.
Vears DF; Metcalfe SA
Eur J Med Genet; 2015 Dec; 58(12):659-67. PubMed ID: 26563495
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive prenatal genetic testing: a study of public attitudes.
Kelly SE; Farrimond HR
Public Health Genomics; 2012; 15(2):73-81. PubMed ID: 22094262
[TBL] [Abstract][Full Text] [Related]
37. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
Eng CM; Desnick RJ
Adv Genet; 2001; 44():275-96. PubMed ID: 11596990
[TBL] [Abstract][Full Text] [Related]
38. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
Beard CA; Amor DJ; Di Pietro L; Archibald AD
Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
[TBL] [Abstract][Full Text] [Related]
39. Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom.
Hill M; Lewis C; Jenkins L; Allen S; Elles RG; Chitty LS
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S119-26. PubMed ID: 22500945
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.
Freeman K; Szczepura A; Osipenko L
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):91-8. PubMed ID: 19081172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
